amodiaquine has been researched along with desethylamodiaquine in 79 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 8 (10.13) | 18.7374 |
1990's | 9 (11.39) | 18.2507 |
2000's | 25 (31.65) | 29.6817 |
2010's | 30 (37.97) | 24.3611 |
2020's | 7 (8.86) | 2.80 |
Authors | Studies |
---|---|
Basco, LK; Le Bras, J | 2 |
el Benna, J; Labro, MT | 1 |
Basco, LK | 2 |
Bryskier, A; Chrétien, P; Lafont, O; Ménager, S | 1 |
Breckenridge, AM; Coleman, JW; Maggs, JL; Park, BK; Winstanley, PA | 1 |
Breckenridge, AM; Edwards, G; Kofi-Ekue, JM; Orme, ML; Salako, LA; Simooya, O; Walker, O; Winstanley, PA | 1 |
Boudreau, EF; Childs, GE; Davidson, DE; Milhous, WK; Pang, L; Pooyindee, N; Wimonwattratee, T | 1 |
Drouville, C; Guigon, D; Le Bras, J; Porte, J; Simon, F; Verdier, F | 1 |
Biaud, JM; Calmel, MB; Clausse, JL; Deloron, P; Hatin, I; Le Bras, J; Marchais, H; Porte, J; Ramanamirija, JA; Simon, F | 1 |
Coulanges, P; Le Bras, J; Marchais, H; Ramanamirija, JA | 1 |
Breckenridge, AM; Edwards, G; Orme, ML; Winstanley, PA | 1 |
Breckenridge, A; Edwards, G; Orme, M; Winstanley, P | 1 |
Blayo, MC; Faurisson, F; Pussard, E; Verdier, F | 1 |
Idowu, OR; Salako, LA | 1 |
Jewell, H; Maggs, JL; O'Neill, PM; Park, BK; Tingle, MD | 1 |
Baba, H; Campistron, G; Chretien, P; Coulais, Y; Laurent, F; Magnaval, JF; Peyron, F; Saivin, S; Sqalli, A; Tufenkji, AE | 1 |
Basco, LK; Keundjian, A; Ringwald, P; Same Ekobo, A | 1 |
Andersson, TB; Björkman, A; Li, XQ; Masimirembwa, CM; Ridderström, M | 1 |
Warhurst, DC | 1 |
Gitau, EN; Githiga, IM; Kokwaro, GO; Muchohi, SN; Ogutu, BR | 1 |
Aubouy, A; Bakary, M; Deloron, P; Keundjian, A; Le Bras, J; Mayombo, J | 1 |
Björkman, A; Gil, JP; Mariga, ST; Sisowath, C; Wernsdorfer, WH | 1 |
Björkman, A; Ferreira, PM; Gil, JP; Holmgren, G; Obonyo, CO; Veiga, MI | 1 |
D'Alessandro, U; Erhart, A; Karema, C; Mupfasoni, D; Rusanganwa, E; Rwagacondo, C; Tinto, H; Van Marck, E; Van Overmeir, C; Vandoren, W | 1 |
Bertilsson, L; Gustafsson, LL; Mahindi, M; Nordmark, A; Pihlsgård, M; Wennerholm, A | 1 |
Bell, DJ; Molyneux, ME; Nyirongo, SK; Ward, SA; Winstanley, PA | 1 |
Goldstein, JA; Kroetz, DL; Ouedraogo, JB; Parikh, S; Rosenthal, PJ | 1 |
Andrianantenaina, HB; Ariey, F; Domarle, O; Randrianarivelojosia, M; Rason, MA; Raveloson, A | 1 |
Ali, AS; Ashton, M; Bhattarai, A; Björkman, A; Hietala, SF; Hombhanje, FW; Kaneko, A; Msellem, M; Röshammar, D; Strömberg, J | 1 |
Beck, O; Gustafsson, LL; Mahindi, M; Ntale, M; Ogwal-Okeng, JW | 1 |
Chen, X; Dai, X; Deng, P; Zhong, D | 1 |
Björkman, A; Echeverry, DF; Gil, JP; Higuita, JC; Holmgren, G; Murillo, C; Osorio, L | 1 |
Dravid, PV; Frye, RF | 1 |
Stepniewska, K; White, NJ | 1 |
Arango, E; Cravo, P; Do Rosário, VE; Maestre, A; Restrepo-Pineda, E | 1 |
Amalvict, R; Baret, E; Briolant, S; Fontaine, A; Fraisse, L; Fusaï, T; Henry, M; Mosnier, J; Pradines, B; Rogier, C | 1 |
Adjei, GO; Alifrangis, M; Goka, BQ; Hoegberg, LC; Kristensen, K; Kurtzhals, JA; Rodrigues, OP | 1 |
Le Hesran, JY; Sakho, M; Sarrassat, S | 1 |
Lai, CS; Mansor, SM; Muniandy, A; Nair, NK; Navaratnam, V; Olliaro, PL | 1 |
Joloba, M; Kiggundu, M; Nawaz, F; Nsobya, SL; Rosenthal, PJ | 1 |
Carn, G; Jullien, V; Juma, E; Kiechel, JR; Obonyo, C; Ogutu, B | 1 |
Almeras, L; Amalvict, R; Baret, E; Briolant, S; Gil, M; Henry, M; Parquet, V; Pradines, B; Rogier, C; Wurtz, N | 1 |
Blair, S; Deharo, E; Pabón, A | 1 |
Fortin, A; Jansen, FH; Verbeeck, RK | 1 |
Adewoye, EO; Folarin, O; Gbotosho, GO; Happi, CT; Michael, OS; Okuboyejo, TM; Sijuade, AO; Sowunmi, A | 1 |
Assi, SB; Basco, LK; Bla, KB; Djaman, AJ; Koné, M; Mazabraud, A; Yavo, W | 1 |
Amalvict, R; Baret, E; Briolant, S; Charras, S; Feraud, M; Henry, M; Huyghues des Etages, E; Pascual, A; Pradines, B; Rogier, C | 1 |
Cammas, M; Hsi, P; Jullien, V; Lindegardh, N; McGready, R; Nosten, F; Phyo, AP; Rijken, MJ; Singhasivanon, P; Tarning, J; White, NJ; Win, AK | 1 |
Adjalley, SH; Eappen, AG; Eastman, RT; Ekland, EH; Fidock, DA; Hoffman, SL; Johnston, GL; Lee, MC; Li, T; Richman, A; Sim, BK | 1 |
Anvikar, AR; Bhatt, RM; Dash, AP; Ghosh, SK; Kumar, A; Mohanty, SS; Pillai, CR; Sharma, B; Sharma, SK; Valecha, N | 1 |
Bergstrand, M; Cammas, M; Chotsiri, P; Day, NP; Jullien, V; Lindegardh, N; McGready, R; Nosten, F; Rijken, MJ; Singhasivanon, P; Tarning, J; White, NJ | 1 |
Ismail, R; Muthiah, YD; Ong, CE; Sulaiman, SA; Tan, SC | 1 |
Ali, A; Björkman, A; Ferreira, PE; Fröberg, G; Gil, JP; Mårtensson, A | 1 |
Adjei, GO; Alifrangis, M; Goka, BQ; Hoegberg, LC; Kurtzhals, JA; Oduro-Boatey, C; Rodrigues, OP | 1 |
Cooksey, R; Dahlström, S; Fairhurst, RM; Flegg, JA; Guerin, PJ; Johnson, JD; Le Bras, J; Le Nagard, H; Lim, P; Ménard, D; Mentré, F; Murillo, C; Musset, L; Noedl, H; Nosten, F; Nsobya, SL; Pradines, B; Quashie, NB; Sibley, CH; Sinou, V; Sriprawat, K; Woodrow, CJ | 1 |
Aubouy, A; Dahlström, S; Deloron, P; Ezinmègnon, S; Faucher, JF; Houzé, P; Houzé, S; Kendjo, E; Le Bras, J; Maïga-Ascofaré, O; Massougbodji, A; Wakpo, A | 1 |
Baret, E; Bercion, R; Camara, C; Diatta, B; Diémé, Y; Fall, B; Fall, KB; Fall, M; Mbaye, PS; Nakoulima, A; Pascual, A; Pradines, B; Wade, B; Wurtz, N | 1 |
Albassam, AA; Frye, RF; Mohamed, ME | 1 |
Bigira, V; Bloome, J; Byaruhanga, O; Conrad, MD; Cooper, RA; Dorsey, G; Greenhouse, B; Gut, J; Havlir, DV; Kakuru, A; Kamya, MR; Kapisi, J; Kozak, B; LeClair, N; Legac, J; Nakazibwe, C; Nsobya, SL; Okiring, J; Rosenthal, PJ; Tumwebaze, P; Walakira, A | 1 |
Hirasawa, N; Hiratsuka, M; Maekawa, M; Mano, N; Oda, A; Saito, T; Tsukada, C | 1 |
Jangid, AG; Mistri, HN; Patel, KR; Rathod, DM; Sanyal, M; Shrivastav, PS | 1 |
Amalvict, R; Camara, C; Diatta, B; Diémé, Y; Fall, B; Fall, M; Madamet, M; Nakoulima, A; Pradines, B; Wade, B | 1 |
Craig, JC; Raheem, KS; Warhurst, DC | 1 |
Commandeur, JN; Vermeulen, NP; Zhang, Y | 1 |
Amalvict, R; Benoit, N; Briolant, S; Diatta, B; Diawara, S; Diémé, Y; Fall, B; Fall, M; Gendrot, M; Kounta, MB; Madamet, M; Nakoulima, A; Pradines, B; Wade, B; Wade, KA | 1 |
Amalvict, R; Bercion, R; Diatta, B; Diawara, S; Fall, B; Gueye, MW; Kounta, MB; Lo, G; Madamet, M; Nakoulima, A; Pradines, B; Wade, KA | 1 |
Commandeur, JNM; den Braver-Sewradj, SP; Vermeulen, NPE; Vos, JC; Zhang, Y | 1 |
Byaruhanga, O; Ceja, FG; Conrad, MD; Cooper, RA; Katairo, T; Nsobya, SL; Rasmussen, SA; Rosenthal, PJ; Tumwebaze, PK | 1 |
Anh, CX; Birrell, GW; Chavchich, M; Edstein, MD; Quang, NN; Rowcliffe, K; Travers, T; van Breda, K | 1 |
Adeagbo, BA; Bolaji, OO; Olawoye, OS | 1 |
Beland, FA; Chen, S; Fang, JL; Tang, Y; Wu, Q | 1 |
Adeagbo, BA; Adehin, A; Adepiti, AO; Bolaji, OO; Elujoba, AA | 1 |
Assao, B; Blessborn, D; Coldiron, ME; Ding, J; Grais, RF; Guindo, O; Koscalova, A; Langendorf, C; Tarning, J; Winterberg, M | 1 |
Bonkian, LN; d'Alessandro, U; Kazienga, A; Lingani, M; Mens, PF; Ouédraogo, JB; Ravinetto, R; Schallig, HDFH; Sorgho, H; Tinto, H; Valéa, I; Yerbanga, I | 1 |
Bazié, T; Dabiré, RK; Ehrlich, HY; Foy, BD; Goodwin, J; Lehane, A; Neya, C; Ouattara, JM; Ouédraogo, JB; Parikh, S; Somé, FA; Wade, M; Zachari, K | 1 |
Blessborn, D; Kaewkhao, K; Tarning, J | 1 |
Burton, RB; Capel, RA; Chan, XHS; Chotsiri, P; Cremer, MA; Hanafiah, M; Hanboonkunupakarn, B; Kiechel, JR; Lee, SJ; Ogutu, B; Pike, J; Tarning, J; Taylor, WRJ; White, NJ; Win, YN | 1 |
12 trial(s) available for amodiaquine and desethylamodiaquine
Article | Year |
---|---|
Effect of dose size on amodiaquine pharmacokinetics after oral administration.
Topics: Administration, Oral; Adult; Amodiaquine; Chromatography, High Pressure Liquid; Humans; Male; Middle Aged | 1987 |
Amodiaquine, its desethylated metabolite, or both, inhibit the metabolism of debrisoquine (CYP2D6) and losartan (CYP2C9) in vivo.
Topics: Administration, Oral; Adult; Amodiaquine; Antihypertensive Agents; Antimalarials; Area Under Curve; Aryl Hydrocarbon Hydroxylases; Confidence Intervals; Cytochrome P-450 CYP2C9; Cytochrome P-450 CYP2D6; Debrisoquin; Drug Interactions; Humans; Losartan; Middle Aged; Phenotype; Time Factors | 2006 |
Effect of concomitant artesunate administration and cytochrome P4502C8 polymorphisms on the pharmacokinetics of amodiaquine in Ghanaian children with uncomplicated malaria.
Topics: Amodiaquine; Antimalarials; Artemisinins; Artesunate; Aryl Hydrocarbon Hydroxylases; Child; Child, Preschool; Cytochrome P-450 CYP2C8; Drug Therapy, Combination; Female; Ghana; Humans; Malaria, Falciparum; Male; Polymorphism, Genetic; Treatment Outcome | 2008 |
Validation of high performance liquid chromatography-electrochemical detection methods with simultaneous extraction procedure for the determination of artesunate, dihydroartemisinin, amodiaquine and desethylamodiaquine in human plasma for application in c
Topics: Administration, Oral; Amodiaquine; Antimalarials; Artemisinins; Artesunate; Chromatography, High Pressure Liquid; Drug Combinations; Drug Stability; Electrochemistry; Humans; Solid Phase Extraction | 2009 |
Selection of parasites with diminished drug susceptibility by amodiaquine-containing antimalarial regimens in Uganda.
Topics: Amino Acid Sequence; Amodiaquine; Antimalarials; Artemether, Lumefantrine Drug Combination; Artemisinins; Artesunate; Child; Child, Preschool; Cohort Studies; Drug Combinations; Drug Resistance; Ethanolamines; Fluorenes; Humans; Infant; Malaria, Falciparum; Molecular Sequence Data; Multidrug Resistance-Associated Proteins; Plasmodium falciparum; Polymorphism, Genetic; Pyrimethamine; Sequence Alignment; Sulfadoxine; Uganda | 2009 |
Population pharmacokinetics and pharmacodynamic considerations of amodiaquine and desethylamodiaquine in Kenyan adults with uncomplicated malaria receiving artesunate-amodiaquine combination therapy.
Topics: Adolescent; Adult; Amodiaquine; Antimalarials; Artemisinins; Drug Combinations; Female; Half-Life; Humans; Kenya; Malaria, Falciparum; Male; Middle Aged; Models, Biological; Treatment Outcome; Young Adult | 2010 |
Comparative oral bioavailability of non-fixed and fixed combinations of artesunate and amodiaquine in healthy Indian male volunteers.
Topics: Administration, Oral; Adolescent; Adult; Amodiaquine; Analysis of Variance; Antimalarials; Area Under Curve; Artemisinins; Artesunate; Biological Availability; Chromatography, High Pressure Liquid; Cross-Over Studies; Dose-Response Relationship, Drug; Drug Combinations; Drug Therapy, Combination; Humans; India; Male; Middle Aged; Tablets; Tandem Mass Spectrometry; Therapeutic Equivalency; Young Adult | 2011 |
Therapeutic efficacy of artesunate-amodiaquine combinations and the plasma and saliva concentrations of desethylamodiaquine in children with acute uncomplicated Plasmodium falciparum malaria.
Topics: Acute Disease; Administration, Oral; Amodiaquine; Antimalarials; Artemisinins; Child; Child, Preschool; Chromatography, High Pressure Liquid; Drug Administration Schedule; Drug Combinations; Drug Therapy, Combination; Female; Follow-Up Studies; Half-Life; Humans; Infant; Malaria, Falciparum; Male; Metabolic Clearance Rate; Saliva; Treatment Outcome | 2013 |
Pharmacokinetics of amodiaquine and desethylamodiaquine in pregnant and postpartum women with Plasmodium vivax malaria.
Topics: Adolescent; Adult; Amodiaquine; Antimalarials; Female; Humans; Malaria, Vivax; Postpartum Period; Pregnancy; Young Adult | 2011 |
Electrocardiographic study in Ghanaian children with uncomplicated malaria, treated with artesunate-amodiaquine or artemether-lumefantrine.
Topics: Adolescent; Amodiaquine; Antimalarials; Artemether, Lumefantrine Drug Combination; Artemisinins; Bradycardia; Child; Child, Preschool; Drug Combinations; Electrocardiography; Ethanolamines; Female; Fluorenes; Ghana; Humans; Infant; Malaria; Male; Risk Factors | 2012 |
Changing Antimalarial Drug Sensitivities in Uganda.
Topics: Adolescent; Amodiaquine; Antimalarials; Artemisinins; Aspartic Acid Endopeptidases; Child; Child, Preschool; Chloroquine; Drug Resistance; Ethanolamines; Female; Fluorenes; Gene Expression; Humans; Infant; Inhibitory Concentration 50; Lumefantrine; Malaria, Falciparum; Male; Mefloquine; Membrane Transport Proteins; Multidrug Resistance-Associated Proteins; Mutation; Parasitic Sensitivity Tests; Plasmodium falciparum; Protozoan Proteins; Quinolines; Uganda; Young Adult | 2017 |
In vivo/ex vivo efficacy of artemether-lumefantrine and artesunate-amodiaquine as first-line treatment for uncomplicated falciparum malaria in children: an open label randomized controlled trial in Burkina Faso.
Topics: Adolescent; Amodiaquine; Antimalarials; Artemether, Lumefantrine Drug Combination; Artemisinins; Artesunate; Burkina Faso; Child; Child, Preschool; Drug Combinations; Drug Therapy, Combination; Female; Humans; Infant; Inhibitory Concentration 50; Lumefantrine; Malaria, Falciparum; Male; Mass Drug Administration; Plasmodium falciparum; Treatment Failure; Treatment Outcome | 2020 |
67 other study(ies) available for amodiaquine and desethylamodiaquine
Article | Year |
---|---|
In vitro activity of pyronaridine against African strains of Plasmodium falciparum.
Topics: Africa; Aminoquinolines; Amodiaquine; Animals; Antimalarials; Chloroquine; Dose-Response Relationship, Drug; Drug Resistance; Naphthyridines; Plasmodium falciparum | 1992 |
Effect of monodesethyl amodiaquine on human polymorphonuclear neutrophil functions in vitro.
Topics: Amodiaquine; Cell Movement; Cell-Free System; Humans; In Vitro Techniques; Neutrophils; Oxygen Consumption; Peroxidase; Phagocytosis; Superoxides | 1991 |
Inefficacy of amodiaquine against chloroquine-resistant malaria.
Topics: Amodiaquine; Animals; Chloroquine; Drug Resistance; Humans; In Vitro Techniques; Plasmodium falciparum | 1991 |
[Preparation of monodesethylamodiaquine from human urine].
Topics: Amodiaquine; Antimalarials; Chromatography, Thin Layer; Female; Humans; Magnetic Resonance Spectroscopy; Mass Spectrometry | 1990 |
The toxicity of amodiaquine and its principal metabolites towards mononuclear leucocytes and granulocyte/monocyte colony forming units.
Topics: Amodiaquine; Bone Marrow; Bone Marrow Cells; Cell Survival; Chloroquine; Colony-Forming Units Assay; Granulocytes; Humans; In Vitro Techniques; Leukocytes, Mononuclear | 1990 |
The disposition of amodiaquine in Zambians and Nigerians with malaria.
Topics: Administration, Oral; Adolescent; Adult; Amodiaquine; Erythrocytes; Female; Humans; Malaria; Male; Middle Aged; Nigeria; Zambia | 1990 |
A comparison of the in vitro activities of amodiaquine and desethylamodiaquine against isolates of Plasmodium falciparum.
Topics: Amodiaquine; Animals; Antimalarials; Chloroquine; Drug Resistance; Mefloquine; Plasmodium falciparum; Quinolines; Thailand | 1989 |
[Drug sensitivity of malaria in a population of children in Pointe-Noire, Congo, in the first half of 1986].
Topics: Adolescent; Amodiaquine; Animals; Antimalarials; Child; Child, Preschool; Chloroquine; Congo; Drug Resistance; Humans; Infant; Malaria; Plasmodium falciparum | 1987 |
[Sensitivity of Plasmodium falciparum to quinolines and therapeutic strategies: comparison of the situation in Africa and Madagascar between 1983 and 1986].
Topics: Amodiaquine; Angola; Animals; Antimalarials; Burkina Faso; Cameroon; Chloroquine; Drug Resistance; Humans; Madagascar; Malaria; Mefloquine; Plasmodium falciparum; Quinine; Quinolines | 1987 |
[In vivo and in vitro sensitivity to 4-aminoquinolines of Plasmodium falciparum in Madagascar: results of a study conducted on the east coast (July 1985-July 1986)].
Topics: Adolescent; Adult; Aminoquinolines; Amodiaquine; Animals; Child; Child, Preschool; Chloroquine; Drug Resistance; Humans; Infant; Madagascar; Malaria; Plasmodium falciparum | 1987 |
The disposition of amodiaquine in man after oral administration.
Topics: Administration, Oral; Adult; Amodiaquine; Chloroquine; Erythrocytes; Humans; Kinetics; Male; Mass Spectrometry | 1987 |
[Pharmacokinetics of amodiaquine and prevention of Plasmodium falciparum malaria].
Topics: Adult; Amodiaquine; Female; Half-Life; Humans; Malaria; Male; Middle Aged; Plasmodium falciparum | 1985 |
Failure to detect amodiaquine in the blood after oral administration.
Topics: Administration, Oral; Adult; Amodiaquine; Chromatography, High Pressure Liquid; Erythrocytes; Humans; Kinetics; Male; Time Factors | 1985 |
The bioactivation of amodiaquine by human polymorphonuclear leucocytes in vitro: chemical mechanisms and the effects of fluorine substitution.
Topics: Amodiaquine; Antimalarials; Biotransformation; Fluorine; Glutathione; Humans; Neutrophil Activation; Neutrophils; Serum Albumin; Tetradecanoylphorbol Acetate | 1995 |
Pharmacokinetic and pharmacodynamic study of amodiaquine and its two metabolites after a single oral dose in human volunteers.
Topics: Adult; Amodiaquine; Animals; Chloroquine; Diffusion Chambers, Culture; Erythrocytes; Half-Life; Humans; Leukocytes; Male; Plasmodium falciparum; Spectrophotometry, Ultraviolet | 1993 |
In vitro activity of monodesethylamodiaquine and amopyroquine against African isolates and clones of Plasmodium falciparum.
Topics: Aminoquinolines; Amodiaquine; Animals; Antimalarials; Chloroquine; Drug Resistance; Humans; Plasmodium falciparum; Regression Analysis | 1993 |
Chemoresistance of Plasmodium falciparum in the urban region of Yaounde, Cameroon. Part 2: Evaluation of the efficacy of amodiaquine and sulfadoxine-pyrimethamine combination in the treatment of uncomplicated Plasmodium falciparum malaria in Yaounde, Came
Topics: Adolescent; Adult; Aged; Amodiaquine; Animals; Antimalarials; Cameroon; Child; Drug Combinations; Female; Humans; Malaria, Falciparum; Male; Middle Aged; Parasitic Sensitivity Tests; Plasmodium falciparum; Pyrimethamine; Sulfadoxine; Treatment Outcome; Urban Health | 2000 |
Amodiaquine clearance and its metabolism to N-desethylamodiaquine is mediated by CYP2C8: a new high affinity and turnover enzyme-specific probe substrate.
Topics: Amodiaquine; Antimalarials; Aryl Hydrocarbon Hydroxylases; Biotransformation; Chromatography, High Pressure Liquid; Cytochrome P-450 CYP2C8; Cytochrome P-450 Enzyme Inhibitors; Cytochrome P-450 Enzyme System; Dealkylation; Humans; In Vitro Techniques; Isoenzymes; Liver; Mass Spectrometry; Microsomes, Liver; Models, Molecular; Recombinant Proteins; Spectrophotometry, Ultraviolet; Steroid 16-alpha-Hydroxylase; Steroid Hydroxylases; Substrate Specificity | 2002 |
Molecular epidemiology of malaria in Cameroon. XV. Experimental studies on serum substitutes and supplements and alternative culture media for in vitro drug sensitivity assays using fresh isolates of Plasmodium falciparum.
Topics: Amodiaquine; Animals; Antimalarials; Cameroon; Chloroquine; Culture Media; Humans; Malaria, Falciparum; Parasitic Sensitivity Tests; Plasmodium falciparum; Pyrimethamine; Serum Albumin | 2003 |
Polymorphism in the Plasmodium falciparum chloroquine-resistance transporter protein links verapamil enhancement of chloroquine sensitivity with the clinical efficacy of amodiaquine.
Topics: Amodiaquine; Animals; Antimalarials; Cell Line; Chloride Channels; Chloroquine; Drug Resistance; Drug Synergism; Hydrophobic and Hydrophilic Interactions; Ion Channels; Plasmodium falciparum; Polymorphism, Genetic; Protozoan Proteins; Transfection; Verapamil | 2003 |
Selective and sensitive liquid chromatographic assay of amodiaquine and desethylamodiaquine in whole blood spotted on filter paper.
Topics: Amodiaquine; Calibration; Humans; Reproducibility of Results; Sensitivity and Specificity | 2004 |
Short report: lack of prediction of amodiaquine efficacy in treating Plasmodium falciparum malaria by in vitro tests.
Topics: Amodiaquine; Antimalarials; Child; Child, Preschool; Drug Resistance; Gabon; Humans; In Vitro Techniques; Malaria, Falciparum; Parasitic Sensitivity Tests; Predictive Value of Tests; Treatment Outcome | 2004 |
Synergism between amodiaquine and its major metabolite, desethylamodiaquine, against Plasmodium falciparum in vitro.
Topics: Amodiaquine; Animals; Antimalarials; Culture Media; Drug Synergism; Genes, MDR; Genotype; Membrane Proteins; Membrane Transport Proteins; Plasmodium falciparum; Protozoan Proteins; Reverse Transcriptase Polymerase Chain Reaction | 2004 |
Amodiaquine resistant Plasmodium falciparum malaria in vivo is associated with selection of pfcrt 76T and pfmdr1 86Y.
Topics: Amino Acid Substitution; Amodiaquine; Animals; Antigens, Protozoan; Antimalarials; ATP-Binding Cassette Transporters; Child, Preschool; Drug Resistance; Humans; Infant; Malaria, Falciparum; Membrane Proteins; Membrane Transport Proteins; Plasmodium falciparum; Protozoan Proteins | 2006 |
In-vitro susceptibility of Plasmodium falciparum to monodesethylamodiaquine, dihydroartemisinin and quinine in an area of high chloroquine resistance in Rwanda.
Topics: Adolescent; Adult; Amodiaquine; Animals; Antimalarials; Artemisinins; Child; Child, Preschool; Chloroquine; Drug Resistance, Multiple; Female; Humans; Infant; Inhibitory Concentration 50; Malaria, Falciparum; Male; Middle Aged; Plasmodium falciparum; Quinine; Rwanda; Sesquiterpenes | 2006 |
Practical HPLC methods for the quantitative determination of common antimalarials in Africa.
Topics: Africa; Amodiaquine; Antimalarials; Chloroquine; Chromatography, High Pressure Liquid; Humans; Pyrimethamine; Reproducibility of Results; Sulfadoxine | 2007 |
Amodiaquine metabolism is impaired by common polymorphisms in CYP2C8: implications for malaria treatment in Africa.
Topics: Alkynes; Amodiaquine; Antimalarials; Aryl Hydrocarbon Hydroxylases; Benzoxazines; Burkina Faso; Chromatography, High Pressure Liquid; Cyclopropanes; Cytochrome P-450 CYP2C8; Dose-Response Relationship, Drug; Drug Interactions; Enzyme Inhibitors; Genotype; HIV Protease Inhibitors; Humans; Lopinavir; Malaria, Falciparum; Models, Biological; Polymorphism, Genetic; Pyridines; Pyrimidinones; Pyrones; Reverse Transcriptase Inhibitors; Saquinavir; Spectrophotometry, Ultraviolet; Sulfonamides; Treatment Outcome; Trimethoprim | 2007 |
Prevalent pfmdr1 n86y mutant Plasmodium falciparum in Madagascar despite absence of pfcrt mutant strains.
Topics: Amodiaquine; Animals; Antimalarials; Chloroquine; DNA, Protozoan; Drug Resistance; Humans; Inhibitory Concentration 50; Madagascar; Malaria, Falciparum; Mefloquine; Membrane Transport Proteins; Multidrug Resistance-Associated Proteins; Plasmodium falciparum; Point Mutation; Polymerase Chain Reaction; Polymorphism, Restriction Fragment Length; Prevalence; Protozoan Proteins; Quinine; Rural Population | 2007 |
Population pharmacokinetics of amodiaquine and desethylamodiaquine in pediatric patients with uncomplicated falciparum malaria.
Topics: Amodiaquine; Antimalarials; Child; Child, Preschool; Humans; Infant; Malaria, Falciparum; Models, Biological | 2007 |
A field-adapted HPLC method for determination of amodiaquine and its metabolite in whole blood dried on filter paper.
Topics: Amodiaquine; Antimalarials; Calibration; Chromatography, High Pressure Liquid; Humans; Reproducibility of Results; Sensitivity and Specificity; Time Factors | 2007 |
Simultaneous determination of amodiaquine and its active metabolite in human blood by ion-pair liquid chromatography-tandem mass spectrometry.
Topics: Acetonitriles; Amodiaquine; Chromatography, High Pressure Liquid; Drug Stability; Humans; Male; Sensitivity and Specificity; Tandem Mass Spectrometry | 2007 |
Short report: polymorphisms in the pfcrt and pfmdr1 genes of Plasmodium falciparum and in vitro susceptibility to amodiaquine and desethylamodiaquine.
Topics: Amino Acid Sequence; Amodiaquine; Animals; Antimalarials; Base Sequence; Colombia; Drug Resistance; Inhibitory Concentration 50; Membrane Transport Proteins; Molecular Sequence Data; Multidrug Resistance-Associated Proteins; Parasitic Sensitivity Tests; Plasmodium falciparum; Polymorphism, Single Nucleotide; Protozoan Proteins | 2007 |
Determination of N-desethylamodiaquine by hydrophilic interaction liquid chromatography with tandem mass spectrometry: application to in vitro drug metabolism studies.
Topics: Amodiaquine; Antimalarials; Chromatography, High Pressure Liquid; Data Interpretation, Statistical; Humans; In Vitro Techniques; Indicators and Reagents; Kinetics; Microsomes, Liver; Reference Standards; Reproducibility of Results; Solvents; Tandem Mass Spectrometry | 2008 |
Pharmacokinetic determinants of the window of selection for antimalarial drug resistance.
Topics: Algorithms; Amodiaquine; Animals; Antimalarials; Artemisinins; Chloroquine; Computer Simulation; Drug Resistance; Malaria; Mefloquine; Models, Theoretical; Pyrimethamine; Quinine | 2008 |
Studies on antimalarial drug susceptibility in Colombia, in relation to Pfmdr1 and Pfcrt.
Topics: Amodiaquine; Animals; Antimalarials; Chloroquine; Colombia; Drug Resistance; Humans; Malaria, Falciparum; Mefloquine; Membrane Transport Proteins; Multidrug Resistance-Associated Proteins; Parasitic Sensitivity Tests; Plasmodium falciparum; Polymerase Chain Reaction; Polymorphism, Restriction Fragment Length; Polymorphism, Single Nucleotide; Protozoan Proteins | 2008 |
In vitro activity of ferroquine is independent of polymorphisms in transport protein genes implicated in quinoline resistance in Plasmodium falciparum.
Topics: Aminoquinolines; Amodiaquine; Animals; Chloroquine; Drug Resistance, Bacterial; Ferrous Compounds; Mefloquine; Membrane Transport Proteins; Metallocenes; Microsatellite Repeats; Molecular Structure; Plasmodium falciparum; Polymorphism, Genetic; Polymorphism, Single Nucleotide; Protozoan Proteins; Quinolines | 2008 |
Biological measure of compliance to Artesunate plus Amodiaquine association: interest in a Mono-Desethyl-Amodiaquine blood assay?
Topics: Adult; Amodiaquine; Animals; Antimalarials; Artemisinins; Chromatography, High Pressure Liquid; Drug Combinations; Female; Humans; Malaria; Male; Patient Compliance; Young Adult | 2009 |
Synergy of mefloquine activity with atorvastatin, but not chloroquine and monodesethylamodiaquine, and association with the pfmdr1 gene.
Topics: Amodiaquine; Antimalarials; Atorvastatin; Chloroquine; DNA, Protozoan; Drug Synergism; Gene Dosage; Genotype; Heptanoic Acids; Humans; Inhibitory Concentration 50; Mefloquine; Multidrug Resistance-Associated Proteins; Parasitic Sensitivity Tests; Plasmodium falciparum; Pyrroles | 2010 |
Plasmodium falciparum: Solanum nudum SN-1 steroid antiplasmodial activity when combined with antimalarial drugs.
Topics: Amodiaquine; Antimalarials; Artemisinins; Atovaquone; Chloroquine; Drug Synergism; Erythrocytes; Flow Cytometry; Humans; Phytosterols; Plasmodium falciparum; Quinine; Solanum; Trophozoites | 2011 |
In vitro susceptibility of Plasmodium falciparum to monodesethylamodiaquine, quinine, mefloquine and halofantrine in Abidjan (Côte d'Ivoire).
Topics: Adolescent; Adult; Amodiaquine; Antimalarials; Child; Child, Preschool; Cote d'Ivoire; Drug Resistance; Female; Humans; Malaria, Falciparum; Male; Mefloquine; Microbial Sensitivity Tests; Middle Aged; Phenanthrenes; Plasmodium falciparum; Quinine; Young Adult | 2010 |
In vitro activity of Proveblue (methylene blue) on Plasmodium falciparum strains resistant to standard antimalarial drugs.
Topics: Amodiaquine; Antimalarials; Chloroquine; Ethanolamines; Fluorenes; Inhibitory Concentration 50; Lumefantrine; Mefloquine; Methylene Blue; Plasmodium falciparum; Polymorphism, Genetic; Protozoan Proteins; Quinine | 2011 |
Quantitative assessment of Plasmodium falciparum sexual development reveals potent transmission-blocking activity by methylene blue.
Topics: Amodiaquine; Animals; Anopheles; Antimalarials; Artemisinins; Blotting, Southern; Dose-Response Relationship, Drug; Ethanolamines; Fluorenes; Genetic Vectors; Germ Cells, Plant; Green Fluorescent Proteins; Luciferases; Lumefantrine; Malaria; Methylene Blue; Naphthyridines; Plasmodium falciparum; Quinolines; Sexual Development | 2011 |
In vitro assessment of drug resistance in Plasmodium falciparum in five States of India.
Topics: Amodiaquine; Artemisinins; Artesunate; Biomarkers, Pharmacological; Chloroquine; Drug Resistance; Humans; In Vitro Techniques; India; Mefloquine; Membrane Transport Proteins; Mutation; Plasmodium falciparum; Protozoan Proteins | 2012 |
Population pharmacokinetic and pharmacodynamic modeling of amodiaquine and desethylamodiaquine in women with Plasmodium vivax malaria during and after pregnancy.
Topics: Adolescent; Adult; Amodiaquine; Antimalarials; Biotransformation; Body Weight; Drug Administration Schedule; Female; Humans; Malaria, Vivax; Nonlinear Dynamics; Plasmodium vivax; Pregnancy; Pregnancy Complications, Parasitic; Secondary Prevention | 2012 |
In-vitro inhibitory effect of Tualang honey on cytochrome P450 2C8 activity.
Topics: Amodiaquine; Aryl Hydrocarbon Hydroxylases; Chromatography, High Pressure Liquid; Cytochrome P-450 Enzyme Inhibitors; Dose-Response Relationship, Drug; Food-Drug Interactions; Honey; Inhibitory Concentration 50; Kinetics; Recombinant Proteins | 2012 |
Assessing the cost-benefit effect of a Plasmodium falciparum drug resistance mutation on parasite growth in vitro.
Topics: Amodiaquine; Antimalarials; Biological Transport; Chloroquine; Drug Resistance; Genetic Fitness; Genotype; Malaria, Falciparum; Membrane Transport Proteins; Multidrug Resistance-Associated Proteins; Mutation; Plasmodium falciparum | 2013 |
High-throughput analysis of antimalarial susceptibility data by the WorldWide Antimalarial Resistance Network (WWARN) in vitro analysis and reporting tool.
Topics: Amodiaquine; Antimalarials; Artemisinins; Automation, Laboratory; Chloroquine; Drug Resistance; Drug Therapy, Combination; High-Throughput Screening Assays; Internet; Malaria, Falciparum; Mefloquine; Parasitic Sensitivity Tests; Plasmodium falciparum; Quinine | 2013 |
Plasmodium falciparum Polymorphisms associated with ex vivo drug susceptibility and clinical effectiveness of artemisinin-based combination therapies in Benin.
Topics: Amodiaquine; Antimalarials; Artemisinins; Drug Combinations; Ethanolamines; Female; Fluorenes; Humans; Inhibitory Concentration 50; Lumefantrine; Male; Mefloquine; Membrane Transport Proteins; Multidrug Resistance-Associated Proteins; Plasmodium falciparum; Polymorphism, Single Nucleotide; Protozoan Proteins; Pyrimethamine; Quinine; Sulfadoxine | 2014 |
Role of Pfmdr1 in in vitro Plasmodium falciparum susceptibility to chloroquine, quinine, monodesethylamodiaquine, mefloquine, lumefantrine, and dihydroartemisinin.
Topics: Adult; Amodiaquine; Antimalarials; Artemisinins; Biological Transport; Child; Chloroquine; Drug Resistance; Erythrocytes; Ethanolamines; Female; Fluorenes; Gene Expression; Haplotypes; Humans; Inhibitory Concentration 50; Lumefantrine; Malaria, Falciparum; Male; Mefloquine; Multidrug Resistance-Associated Proteins; Parasitic Sensitivity Tests; Plasmodium falciparum; Polymorphism, Single Nucleotide; Quinine; Senegal | 2014 |
Inhibitory effect of six herbal extracts on CYP2C8 enzyme activity in human liver microsomes.
Topics: Amodiaquine; Cytochrome P-450 CYP2C8; Humans; Inhibitory Concentration 50; Microsomes, Liver; Pioglitazone; Plant Extracts; Thiazolidinediones | 2015 |
Impact of antimalarial treatment and chemoprevention on the drug sensitivity of malaria parasites isolated from ugandan children.
Topics: Amodiaquine; Antimalarials; Artemisinins; Child, Preschool; Chloroquine; Clinical Trials as Topic; Ethanolamines; Fluorenes; Humans; Infant; Lumefantrine; Membrane Transport Proteins; Multidrug Resistance-Associated Proteins; Parasitic Sensitivity Tests; Plasmodium falciparum; Polymorphism, Genetic; Protozoan Proteins; Quinine; Quinolines; Uganda | 2015 |
Functional characterization of 12 allelic variants of CYP2C8 by assessment of paclitaxel 6α-hydroxylation and amodiaquine N-deethylation.
Topics: Alleles; Amodiaquine; Animals; Aryl Hydrocarbon Hydroxylases; Chlorocebus aethiops; Cloning, Molecular; COS Cells; Cytochrome P-450 CYP2C8; Genetic Variation; Genetic Vectors; Humans; Hydroxylation; Models, Molecular; Paclitaxel; Polymorphism, Genetic | 2015 |
Application of an LC-MS/MS method for reliable determination of amodiaquine, N-desethylamodiaquine, artesunate and dihydroartemisinin in human plasma for a bioequivalence study in healthy Indian subjects.
Topics: Amodiaquine; Artemisinins; Artesunate; Chromatography, Liquid; Humans; India; Tandem Mass Spectrometry; Therapeutic Equivalency | 2016 |
Plasmodium falciparum In Vitro Resistance to Monodesethylamodiaquine, Dakar, Senegal, 2014.
Topics: Amodiaquine; Antimalarials; Drug Resistance; Female; Humans; Inhibitory Concentration 50; Malaria, Falciparum; Male; Parasitic Sensitivity Tests; Plasmodium falciparum; Prevalence; Senegal | 2016 |
Influence of LAR and VAR on Para-Aminopyridine Antimalarials Targetting Haematin in Chloroquine-Resistance.
Topics: Amodiaquine; Antimalarials; Biological Transport; Chloroquine; Drug Design; Drug Resistance; Heme; Hemin; Hydrophobic and Hydrophilic Interactions; Plasmodium falciparum; Quinolines; Structure-Activity Relationship; Vacuoles | 2016 |
Characterization of human cytochrome P450 mediated bioactivation of amodiaquine and its major metabolite N-desethylamodiaquine.
Topics: Activation, Metabolic; Amodiaquine; Cytochrome P-450 Enzyme Inhibitors; Cytochrome P-450 Enzyme System; Glutathione; Humans; Microsomes, Liver; Recombinant Proteins | 2017 |
Association between Polymorphisms in the Pf
Topics: Amodiaquine; Antimalarials; Artemisinins; Artesunate; Asparagine; ATP-Binding Cassette Transporters; Chloroquine; Doxycycline; Drug Resistance; Ethanolamines; Fluorenes; Gene Expression; Humans; Inhibitory Concentration 50; Lumefantrine; Malaria, Falciparum; Mefloquine; Naphthyridines; Plasmodium falciparum; Polymorphism, Genetic; Protein Isoforms; Protozoan Proteins; Quinine; Quinolines; Repetitive Sequences, Amino Acid; Senegal | 2017 |
Confirmation of Plasmodium falciparum in vitro resistance to monodesethylamodiaquine and chloroquine in Dakar, Senegal, in 2015.
Topics: Amodiaquine; Antimalarials; Artemisinins; Chloroquine; Drug Resistance; Drug Therapy, Combination; Plasmodium falciparum; Senegal | 2017 |
Human glutathione S-transferases- and NAD(P)H:quinone oxidoreductase 1-catalyzed inactivation of reactive quinoneimines of amodiaquine and N-desethylamodiaquine: Possible implications for susceptibility to amodiaquine-induced liver toxicity.
Topics: Amodiaquine; Biocatalysis; Chemical and Drug Induced Liver Injury; Escherichia coli; Glutathione Transferase; Humans; In Vitro Techniques; Isoenzymes; Microsomes, Liver; NAD(P)H Dehydrogenase (Quinone); Recombinant Proteins; Transfection | 2017 |
Comparison of the Pharmacokinetics and Ex Vivo Antimalarial Activities of Artesunate-Amodiaquine and Artemisinin-Piperaquine in Healthy Volunteers for Preselection Malaria Therapy.
Topics: Amodiaquine; Antimalarials; Area Under Curve; Artemisinins; Biotransformation; Drug Administration Schedule; Drug Combinations; Half-Life; Healthy Volunteers; Humans; Malaria, Falciparum; Male; Parasitic Sensitivity Tests; Plasmodium falciparum; Quinolines; Tablets; Young Adult | 2018 |
Moringa oleifera leaf powder alters the pharmacokinetics of amodiaquine in healthy human volunteers.
Topics: Adult; Amodiaquine; Antimalarials; Female; Healthy Volunteers; Herb-Drug Interactions; Humans; Male; Moringa oleifera; Plant Leaves; Powders; Tablets; Young Adult | 2018 |
Apoptosis contributes to the cytotoxicity induced by amodiaquine and its major metabolite N-desethylamodiaquine in hepatic cells.
Topics: Amodiaquine; Apoptosis; Cell Survival; Cytochrome P-450 Enzyme System; Hep G2 Cells; Humans; Isoenzymes; MAP Kinase Signaling System; Proto-Oncogene Proteins c-bcl-2 | 2020 |
Influence of MAMA decoction, an Herbal Antimalarial, on the Pharmacokinetics of Amodiaquine in Mice.
Topics: Amodiaquine; Animals; Antimalarials; Drug Combinations; Drug Interactions; Female; Herb-Drug Interactions; Malaria; Male; Mice; Models, Animal; Plant Extracts; Plant Leaves | 2020 |
Adherence and Population Pharmacokinetic Properties of Amodiaquine When Used for Seasonal Malaria Chemoprevention in African Children.
Topics: Africa; Amodiaquine; Antimalarials; Case-Control Studies; Chemoprevention; Child, Preschool; Female; Humans; Infant; Malaria; Male; Medication Adherence; Models, Biological; Prospective Studies; Seasons | 2020 |
Investigating selected host and parasite factors potentially impacting upon seasonal malaria chemoprevention in Bama, Burkina Faso.
Topics: Amodiaquine; Antimalarials; Burkina Faso; Chemoprevention; Child, Preschool; Cross-Sectional Studies; Cytochrome P-450 CYP2C8; Drug Resistance; Female; Genes, Protozoan; Humans; Infant; Malaria, Falciparum; Male; Plasma; Polymorphism, Genetic | 2020 |
High-throughput quantitation method for amodiaquine and desethylamodiaquine in plasma using supported liquid extraction technology.
Topics: Amodiaquine; Antimalarials; Chromatography, Liquid; High-Throughput Screening Assays; Humans; Limit of Detection; Linear Models; Liquid-Liquid Extraction; Reproducibility of Results; Tandem Mass Spectrometry | 2021 |
Cardiovascular concentration-effect relationships of amodiaquine and its metabolite desethylamodiaquine: Clinical and preclinical studies.
Topics: Amodiaquine; Animals; Antimalarials; Kenya; Malaria; Mice | 2023 |